News

Filter

Current filters:

NovartisAnti-virals

1 to 9 of 34 results

CSL buys Novartis’ influenza vaccines business for $275 million

CSL buys Novartis’ influenza vaccines business for $275 million

27-10-2014

Swiss pharma major Novartis has agreed to divest its influenza vaccines business to Australia’s CSL…

Anti-viralsbioCSLCSL LimitedFinancialMergers & AcquisitionsNovartisPharmaceuticalVaccines

Novartis returns rights to Enanta’s NS5A Inhibitor EDP-239 for hep C

01-10-2014

USA-based discovery and development company Enanta Pharmaceuticals says it has entered into an agreement…

Anti-viralsEnanta PharmaceuticalsLicensingNovartisPharmaceutical

Novartis’ Bexsero has high uptake in first widespread public vaccination program against meningitis B

Novartis’ Bexsero has high uptake in first widespread public vaccination program against meningitis B

29-07-2014

Swiss drug major Novartis has announced initial results from a large-scale vaccination campaign using…

Anti-viralsBexseroCanadaMeningitis BNovartisPharmaceuticalResearch

MSF warns of US/Indian tension over generic policy discussion

MSF warns of US/Indian tension over generic policy discussion

25-09-2013

Humanitarian group Médecins Sans Frontières has warned that India is facing political pressure from…

Anti-viralsAsia-PacificBayerGenericsGleevecHealthcareNexavarNorth AmericaNovartisPolitics

Switzerland's Lonza involvement in South Africa pharma project in doubt

28-05-2013

The South Africa government is expected to publish a request for information from potential international,…

Anti-viralsGenericsLonzaNovartisProductionRest of the World

1 to 9 of 34 results

Back to top